CIK 0001012477
AVDL AVADEL PHARMACEUTICALS PLC
Insider trading from SEC Form 4. Last filing Feb 18, 2026.
AVADEL PHARMACEUTICALS PLC (AVDL) has 35 SEC Form 4 filings on file from 11 insiders, the latest filed on Feb 18, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
9 open-market trades have been scored at AVDL. The newest: Weiss Asset Management LP sold $233M of stock on Feb 13, 2026, filed Feb 18, 2026, scored 53 (moderate). 3 insiders bought within 14 days of each other around Jan 21, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Signals
Open-market buys and sells at AVADEL PHARMACEUTICALS PLC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Weiss Asset Management LP other sell | $233M 11,112,052 shares | -100% | - | |
| 44Moderate | Linda Palczuk director buy | $40k 5,000 shares | +8% | - | |
| 46Moderate | Eric J Ende director buy | $235k 30,000 shares | +17% | - | |
| 42Moderate | Peter J. Thornton director buy | $80k 10,000 shares | +11% | - | |
| 42Moderate | Thomas S McHugh Chief Financial Officer buy | $24k 2,300 shares | +3% | - | |
| 47Moderate | Thomas S McHugh Chief Financial Officer buy | $52k 5,000 shares | +6% | - | |
| 35Weak | Linda Palczuk director buy | $31k 3,000 shares | +5% | - | |
| 48Moderate | Geoffrey Michael Glass director buy | $200k 20,279 shares | +34% | - | |
| 58Moderate | Gregory J Divis Chief Executive Officer buy | $100k 10,000 shares | - | - |
Transactions
The newest 50 of 115 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Weiss Asset Management LP other | SOpen-market sale Ordinary Sharesindirect: See Footnote 2 | -11,112,052 | $21.00 | $233M | 0 | Feb 18, 2026 |
| Feb 12, 2026 | Jerad G. Seurer Gen. Counsel & Corp. Secretary | DDisposition to issuer Ordinary Shares | -23,496 | $21.00 | $493k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Ordinary Shares | -211,105 | $21.00 | $4.4M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Naseem Amin director | DDisposition to issuer Ordinary Shares | -22,000 | $21.00 | $462k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Peter J. Thornton director | DDisposition to issuer Ordinary Shares | -115,060 | $21.00 | $2.4M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Eric J Ende director | DDisposition to issuer Ordinary Shares | -219,905 | $21.00 | $4.6M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Susan Rodriguez Chief Operating Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -300,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Ordinary Shares | -22,005 | $21.00 | $462k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Ordinary Shares | -22,000 | $21.00 | $462k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Linda Palczuk director | DDisposition to issuer Ordinary Shares | -78,905 | $21.00 | $1.7M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Ordinary Shares | -100,400 | $21.00 | $2.1M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Jerad G. Seurer Gen. Counsel & Corp. Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -25,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Linda Palczuk director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -250,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Eric J Ende director | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,057 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Ordinary Sharesindirect: By McCamish Charitable Remainder Trust | -67,025 | $21.00 | $1.4M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Naseem Amin director | DDisposition to issuer Stock Option (Right to Buy)derivative | -49,500 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Ordinary Sharesindirect: By Trust | -69,075 | $21.00 | $1.5M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Peter J. Thornton director | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Ordinary Sharesindirect: By Trust | -10,000 | $21.00 | $210k | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Naseem Amin director | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -150,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Eric J Ende director | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Stock Option (Right to Buy)derivative | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Peter J. Thornton director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Linda Palczuk director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -200,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Jerad G. Seurer Gen. Counsel & Corp. Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Ordinary Sharesindirect: By Trust | -75,904 | $21.00 | $1.6M | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Jerad G. Seurer Gen. Counsel & Corp. Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -80,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Eric J Ende director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Naseem Amin director | DDisposition to issuer Stock Option (Right to Buy)derivative | -11,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -150,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Linda Palczuk director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Peter J. Thornton director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -60,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Linda Palczuk director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -50,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Eric J Ende director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Peter J. Thornton director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Jerad G. Seurer Gen. Counsel & Corp. Secretary | DDisposition to issuer Stock Option (Right to Buy)derivative | -47,500 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -175,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Geoffrey Michael Glass director | DDisposition to issuer Stock Option (Right to Buy)derivativeindirect: By Trust | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Thomas S McHugh Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -157,500 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Mark Anthony McCamish director | DDisposition to issuer Stock Option (Right to Buy)derivative | -42,000 | - | - | 0 | Feb 12, 2026 |
| Feb 12, 2026 | Gregory J Divis Chief Executive Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Feb 12, 2026 |
50 of 115 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Naseem Amindirector
- Gregory J DivisChief Executive Officer
- Eric J Endedirector
- Geoffrey Michael Glassdirector
- Thomas S McHughChief Financial Officer
- Mark Anthony McCamishdirector
- Linda Palczukdirector
- Susan RodriguezChief Operating Officer
- Jerad G. SeurerGen. Counsel & Corp. Secretary
- Peter J. Thorntondirector
- Weiss Asset Management LPother
Questions about AVDL
Answered from the filings on this page, as of the latest one.
Are insiders buying AVDL?
No. In the last 90 days no insider at AVADEL PHARMACEUTICALS PLC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AVDL on the open market?
Weiss Asset Management LP sold $233M of AVDL on Feb 13, 2026 and filed the Form 4 on Feb 18, 2026. InsiderTell scored 53 (moderate).
How many insiders file Form 4 at AVADEL PHARMACEUTICALS PLC?
11 people have filed a Form 4 at AVADEL PHARMACEUTICALS PLC, among them Naseem Amin (director), Gregory J Divis (Chief Executive Officer), Eric J Ende (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.